Large Compounders’ Reporting Requirements Would Move Closer To Manufacturers’ In Senate Bill

By Derrick Gingery / Email the Author / May 16, 2013 

Word Count: 1079 / Article # 14130516004 / Posted: May 16 2013 6:30 PM

---

Executive Summary

Compounding manufacturers would have to report adverse events and quality problems much like traditional drug and biologic makers as a Senate committee moves toward mark up of legislation.

to purchase to read click here